ReutersIt will take $15 billion in grants during 2022 and another $10 billion annually after that to establish and maintain an adequate toolkit to respond to COVID-19 and address future pandemic threats, according to four organizations focused on global health and the economy.
Face2Face America, a nationwide, community-driven Covid-19 vaccine education initiative, launched a call to action to engage other members of the healthcare communications industry to lend support to their initiative to fight vaccine hesitancy. Face2Face America was created by a consortium of healthcare communications experts that want to educate vaccine hesitant communities about the importance of getting a Covid-19 vaccine.
A first-of-its-kind organization launched on May 13 unifying the voices of life science companies committed to delivering desperately needed treatments to rare disease patients. The Rare Disease Company Coalition’s 10 founding members have brought 22 treatments to market and have more than 160 rare disease programs in the works.
Abbott on March 11 announced the formation of the Abbott Pandemic Defense Coalition, a first-of-its-kind global scientific and public health partnership dedicated to the early detection of, and rapid response to, future pandemic threats.
A “revolution” in technology that helped scientists develop Covid-19 vaccines in under a year must be sped up, so that when the next pandemic arrives a shot can be ready in 100 days, an international coalition said on March 10.
Clover Biopharmaceuticals raised a $230 million series C round co-led by GL Ventures and Temasek, which will push the Chinese fusion protein company’s Covid-19 vaccine into Phase II/III testing and production planning.
Novavax Inc. said the company’s coronavirus vaccine was 89.3% effective in preventing Covid-19 in a trial conducted in the United Kingdom, and was nearly as effective in protecting against the more highly contagious variant first discovered in the UK, according to a preliminary analysis.
An historic alliance of life sciences and healthcare organizations seeks to accelerate the broad adoption of patient-focused, decentralized clinical trials and research.
MJH Life Sciences™ Launches COVID-19 Coalition — Alliance of renowned thought leaders to assemble biweekly to keep health care professionals abreast of emerging COVID-19 science and news. […]
More than 700 companies have joined Time to Vote, a business-led, nonpartisan coalition that aims to increase voter participation in the U.S. elections.
